Treadwell Therapeutics Denmark Finland Germany Netherlands Sweden United Kingdom New York California

Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-402257 for the Treatment of ER+/HER2- Breast Cancer

View original content:https://www.prnewswire.co.uk/news-releases/treadwell-therapeutics-announces-fast-track-designation-granted-by-the-fda-to-cfi-402257-for-the-treatment-of-erher2--breast-cancer-301717751.html